Diligence memo · auto-generated · as of July 2, 2026

Acera Surgical, Inc.

Acera Surgical, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Acera Surgical, Inc. operates in Medical Devices, based in ST. LOUIS.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Acera Surgical, Inc. has raised $6.2M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $5.1M on 2018-10-05.

Most recent recorded round closed around 2018-10-05.

Valuation (modeled)modeled

Provath models Acera Surgical, Inc. at approximately $124M (range $6.3M–$672M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Series A Medical Devices companies in 2016–2018 (5 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 32 months.

Last raise 7.7 yr ago; this sector typically re-raises about every 16 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 8.5× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 71% of Medical Devices peers (233 compared).

Modeled value ranks above 90% of those peers.

Closest niche peers: Fulcrum Implant Systems, Inc., SafeOp Surgical, Inc., Reliant Immune Diagnostics, LLC, Medite Cancer Diagnostics, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.